Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Latrophilins are a subset of adhesion G protein–coupled receptors (adhesion-GPCRs), with three main isoforms: Latrophilin-1 (ADGRL1), Latrophilin-2 (ADGRL2), and Latrophilin-3 (ADGRL3)[4][5][8]. **Latrophilins** are membrane receptors characterized by a large N-terminal extracellular region (including lectin and olfactomedin domains) linked through a GAIN domain to a seven-transmembrane GPCR core[4][5][8]. They are best known as the brain receptors for α-latrotoxin (from black widow spider venom), which triggers massive exocytosis at synapses[4][7]. Functionally, latrophilins mediate both cell adhesion and classical GPCR signal transduction, including constitutive and ligand-induced increases in cAMP[1][3][6]. Latrophilin-2 and Latrophilin-3, in particular, are essential for synapse formation and proper connectivity in the hippocampus, acting postsynaptically in trans-synaptic complexes with proteins such as teneurins and FLRTs[1][3][6][9]. Emerging data suggest roles in heart development (Latrophilin-2), cell proliferation, and cancer stem cell function. While not presently targeted by pharmacological drugs, latrophilins are of increasing interest in neuroscience and regenerative medicine due to their specific and essential signaling roles[5][8].
Agonism by α-latrotoxin triggers exocytosis at neuron synapses (extreme depolarization); Synthetic *Stachel* peptides can activate the receptor via the conserved tethered agonist sequence in the GAIN domain
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Latrophilin G protein-coupled receptor (Latrophilin (Lphn); for individual isoforms: Latrophilin-1 (Lphn1), Latrophilin-2 (Lphn2), Latrophilin-3 (Lphn3)).